File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1159/000046657
- Scopus: eid_2-s2.0-0035702518
- PMID: 11799270
- WOS: WOS:000173207600013
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: CAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans
Title | CAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans |
---|---|
Authors | |
Keywords | Alcaligenes xylosoxidans Continuous ambulatory peritoneal dialysis Peritonitis Treatment, infectious peritonitis |
Issue Date | 2001 |
Publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/AJN |
Citation | American Journal Of Nephrology, 2001, v. 21 n. 6, p. 502-506 How to Cite? |
Abstract | Alcaligenes xylosoxidans is an uncommon cause of peritonitis in patients on maintenance continuous ambulatory peritoneal dialysis (CAPD). Peritonitis caused by A. xylosoxidans usually carries a poor prognosis because of the pathogen's virulence and its universal resistance to most antimicrobial agents. Even after early Tenckhoff catheter removal, the transport property of the peritoneum is often irreversibly damaged, leading to permanent technique failure. We report 2 patients with CAPD-associated peritonitis due to A. xylosoxidans sp. xylosoxidans who were successfully cured with a combination of piperacillin and tazobactam. One of them subsequently returned uneventfully to CAPD. Copyright © 2001 S. Karger AG, Basel. |
Persistent Identifier | http://hdl.handle.net/10722/162548 |
ISSN | 2023 Impact Factor: 4.3 2023 SCImago Journal Rankings: 1.218 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tang, S | en_HK |
dc.contributor.author | Cheng, CC | en_HK |
dc.contributor.author | Tse, KC | en_HK |
dc.contributor.author | Li, FK | en_HK |
dc.contributor.author | Choy, BY | en_HK |
dc.contributor.author | Chan, TM | en_HK |
dc.contributor.author | Lai, KN | en_HK |
dc.date.accessioned | 2012-09-05T05:20:58Z | - |
dc.date.available | 2012-09-05T05:20:58Z | - |
dc.date.issued | 2001 | en_HK |
dc.identifier.citation | American Journal Of Nephrology, 2001, v. 21 n. 6, p. 502-506 | en_HK |
dc.identifier.issn | 0250-8095 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/162548 | - |
dc.description.abstract | Alcaligenes xylosoxidans is an uncommon cause of peritonitis in patients on maintenance continuous ambulatory peritoneal dialysis (CAPD). Peritonitis caused by A. xylosoxidans usually carries a poor prognosis because of the pathogen's virulence and its universal resistance to most antimicrobial agents. Even after early Tenckhoff catheter removal, the transport property of the peritoneum is often irreversibly damaged, leading to permanent technique failure. We report 2 patients with CAPD-associated peritonitis due to A. xylosoxidans sp. xylosoxidans who were successfully cured with a combination of piperacillin and tazobactam. One of them subsequently returned uneventfully to CAPD. Copyright © 2001 S. Karger AG, Basel. | en_HK |
dc.language | eng | en_US |
dc.publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/AJN | en_HK |
dc.relation.ispartof | American Journal of Nephrology | en_HK |
dc.subject | Alcaligenes xylosoxidans | en_HK |
dc.subject | Continuous ambulatory peritoneal dialysis | en_HK |
dc.subject | Peritonitis | en_HK |
dc.subject | Treatment, infectious peritonitis | en_HK |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Alcaligenes | en_US |
dc.subject.mesh | Enzyme Inhibitors - Therapeutic Use | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Gram-Negative Bacterial Infections - Drug Therapy - Etiology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Penicillanic Acid - Analogs & Derivatives - Therapeutic Use | en_US |
dc.subject.mesh | Penicillins - Therapeutic Use | en_US |
dc.subject.mesh | Peritoneal Dialysis, Continuous Ambulatory - Adverse Effects | en_US |
dc.subject.mesh | Peritonitis - Drug Therapy - Microbiology | en_US |
dc.subject.mesh | Piperacillin - Therapeutic Use | en_US |
dc.title | CAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Tang, S: scwtang@hku.hk | en_HK |
dc.identifier.email | Chan, TM: dtmchan@hku.hk | en_HK |
dc.identifier.email | Lai, KN: knlai@hku.hk | en_HK |
dc.identifier.authority | Tang, S=rp00480 | en_HK |
dc.identifier.authority | Chan, TM=rp00394 | en_HK |
dc.identifier.authority | Lai, KN=rp00324 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1159/000046657 | en_HK |
dc.identifier.pmid | 11799270 | - |
dc.identifier.scopus | eid_2-s2.0-0035702518 | en_HK |
dc.identifier.hkuros | 67223 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0035702518&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 21 | en_HK |
dc.identifier.issue | 6 | en_HK |
dc.identifier.spage | 502 | en_HK |
dc.identifier.epage | 506 | en_HK |
dc.identifier.isi | WOS:000173207600013 | - |
dc.publisher.place | Switzerland | en_HK |
dc.identifier.scopusauthorid | Tang, S=7403437082 | en_HK |
dc.identifier.scopusauthorid | Cheng, CC=7404796652 | en_HK |
dc.identifier.scopusauthorid | Tse, KC=7102609864 | en_HK |
dc.identifier.scopusauthorid | Li, FK=8219093900 | en_HK |
dc.identifier.scopusauthorid | Choy, BY=7003465499 | en_HK |
dc.identifier.scopusauthorid | Chan, TM=7402687700 | en_HK |
dc.identifier.scopusauthorid | Lai, KN=7402135706 | en_HK |
dc.identifier.issnl | 0250-8095 | - |